Synthesis and evaluation of condensed magnetic nanocrystal clusters with in vivo multispectral optoacoustic tomography for tumour targeting
Source abstract
Abstract
Colloidal clusters of magnetic iron oxide nanocrystals (MIONs), particularly in the condensed pattern (co-CNCs), have emerged as new superstructures to improve further the performance of MIONs in applications pertaining to magnetic manipulation (drug delivery) and magnetic resonance imaging (MRI). Exploitation of the advantages they represent and their establishment in the area of nanomedicine demands a particular set of assets. The present work describes the development and evaluation of MION-based co-CNCs featuring for the first time such assets: High magnetization, as well as magnetic content and moment, high relaxivities (r2 = 400 and r2* = 905 s(-1) mMFe(-1)) and intrinsic loss power (2.3 nH m(2) kgFe(-1)) are combined with unprecedented colloidal stability and structural integrity, stealth and drug-loading properties. The reported nanoconstructs are endowed with additional important features such as cost-effective synthesis and storage, prolonged self-life and biocompatibility. It is finally showcased with in vivo multispectral optoacoustic tomography how these properties culminate in a system suitable for targeting breast cancer and for forceful in vivo manipulation with low magnetic field gradients.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Photoacoustic and Ultrasonic Imaging · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (78)
Show source-provided references
1. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications10.1016/j.biomaterials.2004.10.012 ↗
2. Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization10.1016/j.biomaterials.2009.08.005 ↗
3. Efficient drug-delivery using magnetic nanoparticles — biodistribution and therapeutic effects in tumour bearing rabbits10.1016/j.nano.2013.05.001 ↗
4. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy10.1016/j.jconrel.2014.07.059 ↗
5. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes10.1021/nn405839n ↗
6. Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines10.1021/nl404391r ↗
7. Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials10.1002/smll.201303627 ↗
8. Dynamic inversion enables external magnets to concentrate ferromagnetic rods to a central target10.1021/nl503654t ↗
9. Co-encapsulation of magnetic nanoparticles and doxorubicin into biodegradable microcarriers for deep tissue targeting by vascular MRI navigation10.1016/j.biomaterials.2010.12.059 ↗
10. Targeted delivery of magnetic aerosol droplets to the lung10.1038/nnano.2007.217 ↗
11. Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy10.1016/S0142-9612(00)00006-5 ↗
12. Theranostics of epitaxially condensed colloidal nanocrystal clusters, through a soft biomineralization route10.1021/cm404053v ↗
13. A simple one-pot self-assembly route to nanoporous and monodispersed Fe3O4 particles with oriented attachment structure and magnetic property10.1021/jp0676843 ↗
14. Mesoporous biocompatible and acid-degradable magnetic colloidal nanocrystal clusters with sustainable stability and high hydrophobic drug loading capacity10.1021/nn103213y ↗
15. Colloidal nanoparticle clusters: functional materials by design10.1039/c2cs35197h ↗
16. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles10.1016/j.biomaterials.2013.06.046 ↗
17. Relaxivity Optimization of a PEGylated iron-oxide-based negative magnetic resonance contrast agent for T2-weighted spin–echo imaging10.1021/nn204591r ↗
18. Multicore assemblies potentiate magnetic properties of biomagnetic nanoparticles10.1002/adma.201102948 ↗
19. Colloidal assemblies of oriented maghemite nanocrystals and their NMR relaxometric properties10.1039/C4DT00024B ↗
20. Iron oxide nanosized clusters embedded in porous nanorods: a new colloidal design to enhance capabilities of MRI contrast agents10.1021/nn9013388 ↗
21. Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents10.1021/nn304477s ↗
22. Colloidal magnetic nanocrystal clusters: variable length-scale interaction mechanisms, synergetic functionalities and technological advantages10.1515/ntrev-2014-0034 ↗
23. Magnetic colloidal supraparticles: design, fabrication and biomedical applications10.1002/adma.201301896 ↗
24. Antibiofouling amphiphilic polymer-coated superparamagnetic iron oxide nanoparticles: synthesis, characterization, and use in cancer imaging in vivo10.1039/b902445j ↗
25. Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery10.1002/adma.200701726 ↗
26. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems10.1021/nl061412u ↗
27. Preparation, stability and cytocompatibility of magnetic/PLA-PEG hybrids10.1039/b9nr00253g ↗
28. Iron oxide @ polypyrrole nanoparticles as a multifunctional drug carrier for remotely controlled cancer therapy with synergistic antitumor effect10.1021/nn4017179 ↗
29. Highly dispersible, superparamagnetic magnetite nanoflowers for magnetic resonance imaging10.1039/B916562B ↗
30. Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging10.1021/nn3046055 ↗
31. Redispersible hybrid nanopowders: cerium oxide nanoparticle complexes with phosphonated-PEG oligomers10.1021/nn700374d ↗
32. PEG-stabilized core–shell nanoparticles: impact of linear versus dendritic polymer shell architecture on colloidal properties and the reversibility of temperature-induced aggregation10.1021/nn304045q ↗
33. Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups10.1021/nl902212q ↗
34. Multidentate catechol-based polyethylene glycol oligomers provide enhanced stability and biocompatibility to iron oxide nanoparticles10.1021/nn203735b ↗
35. Physicochemical aspects of drug delivery and release from polymer-based colloids10.1016/S1359-0294(00)00046-7 ↗
36. Molecular imaging by means of multispectral optoacoustic tomography (MSOT)10.1021/cr9002566 ↗
37. Going deeper than microscopy: the optical imaging frontier in biology10.1038/nmeth.1483 ↗
38. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers10.1002/smll.201201779 ↗
39. Liposome–gold Nanorod hybrids for high-resolution visualization deep in tissues10.1021/ja304499q ↗
40. Poly(ethylene glycol) carbodiimide coupling reagents for the biological and chemical functionalization of water-soluble nanoparticles10.1021/nn800870r ↗
41. The effect of nanoparticle polyethylene glycol surface density on ligand-directed tumor targeting studied in vivo by dual modality imaging10.1021/nn301630n ↗
42. Quantifying the coverage density of poly(ethylene glycol) chains on the surface of gold nanostructures10.1021/nn2038516 ↗
43. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake10.1021/ja2084338 ↗
44. Functionalized nanoparticles with long-term stability in biological media10.1002/smll.200801647 ↗
45. Zwitterionic-coated “stealth” nanoparticles for biomedical applications: recent advances in countering biomolecular corona formation and uptake by the mononuclear phagocyte system10.1002/smll.201303540 ↗
46. Tuneable enhancement of the salt and thermal stability of polymeric micelles by cyclized amphiphiles10.1038/ncomms2585 ↗
47. Improving lanthanide nanocrystal colloidal stability in competitive aqueous buffer solutions using multivalent PEG-phosphonate ligands10.1021/la302690h ↗
48. Multiple-interaction ligands inspired by mussel adhesive protein: synthesis of highly stable and biocompatible nanoparticles10.1002/anie.201101521 ↗
49. Preventing corona effects: multiphosphonic acid poly(ethylene glycol) copolymers for stable stealth iron oxide nanoparticles10.1021/bm500832q ↗
50. Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model10.1021/nn200809t ↗
51. Ultrastable, redispersible, small, and highly organomodified mesoporous silica nanotherapeutics10.1021/ja208567v ↗
52. Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging10.1002/smll.200801328 ↗
53. Stimulus-responsive Au@(MeO2MAx-co-OEGMAy) nanoparticles stabilized by non-DLVO interactions: implications of ionic strength and copolymer (x:y) fraction on aggregation kinetics10.1021/la403963c ↗
54. Stealth properties to improve therapeutic efficacy of drug nanocarriers
55. Protein-resistant poly(ethylene oxide)-grafted surfaces: chain density-dependent multiple mechanisms of action10.1021/la702310t ↗
56. Poly(ethylene glycol) and poly(carboxy betaine) based nonfouling architectures: review and current efforts
57. A random Sequential adsorption model for protein adsorption to surfaces functionalized with poly(ethylene oxide)10.1002/adma.200802057 ↗
58. Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA–mPEG nanoparticles10.1016/S0378-5173(03)00224-2 ↗
59. Fabrication of contrast agents for magnetic resonance imaging from polymer-brush-afforded iron oxide magnetic nanoparticles prepared by surface-initiated living radical polymerization10.1021/bm400770n ↗
60. PEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokinetics10.1021/nl302638g ↗
61. One-pot synthesis of highly magnetically sensitive Nanochains coated with a highly Cross-linked and biocompatible polymer10.1002/anie.201003820 ↗
62. Oil phase evaporation-induced self-assembly of hydrophobic nanoparticles into spherical clusters with controlled surface chemistry in an oil-in-water dispersion and comparison of behaviors of individual and clustered iron oxide nanoparticles10.1021/ja102138a ↗
63. Nanobeads highly loaded with superparamagnetic nanoparticles prepared by emulsification and seeded-emulsion polymerization10.1021/la903815t ↗
64. Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T2 relaxation10.1021/nn2002272 ↗
65. Development of high magnetization Fe3O4/polystyrene/silica nanospheres via combined miniemulsion/emulsion polymerization10.1021/ja066165a ↗
66. Chitosan oligosaccharide-stabilized ferrimagnetic iron oxide nanocubes for magnetically modulated cancer hyperthermia10.1021/nn301046w ↗
67. Iron oxide monocrystalline nanoflowers for highly efficient magnetic hyperthermia10.1021/jp3025478 ↗
68. Magnetic hyperthermia10.1039/9781849734844-00060 ↗
69. Merging high doxorubicin loading with pronounced magnetic response and bio-repellent properties in hybrid drug nanocarriers10.1002/smll.201102525 ↗
70. A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T2-contrast agents10.1002/adhm.201200078 ↗
71. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI10.1021/nn406158h ↗
72. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents10.1021/nl071099b ↗
73. Surface design of core–shell superparamagnetic iron oxide nanoparticles drives record relaxivity values in functional MRI contrast agents10.1039/c2cc35515a ↗
74. Monodisperse water-soluble magnetite nanoparticles prepared by polyol process for high-performance magnetic resonance imaging10.1039/b712795b ↗
75. Multispectral opto-acoustic tomography of deep-seated fluorescent proteins in vivo10.1038/nphoton.2009.98 ↗
76. Dynamic imaging of PEGylated indocyanine green (ICG) liposomes within the tumor microenvironment using multi-spectral optoacoustic tomography (MSOT)10.1016/j.biomaterials.2014.10.014 ↗
77. Programmed co-delivery of paclitaxel and doxorubicin boosted by camouflaging with erythrocyte membrane10.1039/C4NR07027E ↗
78. Doxorubicin-loaded magnetic silk fibroin nanoparticles for targeted therapy of multidrug-resistant Cancer10.1002/adma.201403562 ↗